Search - tctmd.com

Displaying 61 - 80 of 242

Sort: Relevancy | Date

News Conference News ESC 2020

Implantation Technique Influences LV Remodeling After TMVR

Todd Neale

September 04, 2020

News Daily News

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

L.A. McKeown

July 27, 2020

News Conference News EuroPCR 2020

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Yael L. Maxwell

July 03, 2020

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

News Daily News

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Michael O'Riordan

June 01, 2020

News Conference News ACC 2020

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

Michael O'Riordan

March 29, 2020

News Daily News

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Yael L. Maxwell

February 28, 2020

News Daily News

ViV TAVR Bests Redo Surgery for Failed Valves: Retrospective Study

Yael L. Maxwell

January 16, 2020

News Daily News

Optimal Implantation Depth With Self-Expanding TAVR? Success May Prove Elusive

Yael L. Maxwell

December 19, 2019

News Daily News

Routine Anticoagulation Seems Warranted After TMVR: Review

Todd Neale

December 04, 2019

News Conference News PCR London Valves 2019

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Michael O'Riordan

November 20, 2019

News Daily News

Early Signs Positive for Tendyne TMVR in Severe MAC

Caitlin E. Cox

September 11, 2019

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

News Conference News EuroPCR 2019

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Caitlin E. Cox

May 24, 2019

News Conference News EuroPCR 2019

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Shelley Wood

May 23, 2019

News Daily News

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Shelley Wood

February 19, 2019

News Daily News

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

L.A. McKeown

February 06, 2019

News Conference News TCT 2018

Higher Risk of Rehospitalization, Mortality in TAVR Patients With Severe Device Mismatch

Lucy Hicks

September 26, 2018

News Conference News PCR London Valves 2018

Small Series Speak to Inching Progress in Off-Label or Expanded TAVR Applications

Shelley Wood

September 10, 2018

News Conference News EuroPCR 2018

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Caitlin E. Cox

May 24, 2018

Advertisement

Implantation Technique Influences LV Remodeling After TMVR

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

ViV TAVR Bests Redo Surgery for Failed Valves: Retrospective Study

Optimal Implantation Depth With Self-Expanding TAVR? Success May Prove Elusive

Routine Anticoagulation Seems Warranted After TMVR: Review

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Early Signs Positive for Tendyne TMVR in Severe MAC

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

Higher Risk of Rehospitalization, Mortality in TAVR Patients With Severe Device Mismatch

Small Series Speak to Inching Progress in Off-Label or Expanded TAVR Applications

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content